Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02010242
What this trial is testing

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Who this might be right for
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Calliditas Therapeutics AB 136
Not applicableStudy completedNCT05357742
What this trial is testing

Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease

Who this might be right for
Diabetic NephropathiesDiabetes Mellitus, Type 2Chronic Kidney Diseases+1 more
Medical College of Wisconsin 50
Post-approval studies (Phase 4)UnknownNCT03664414
What this trial is testing

Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)

Who this might be right for
Chronic Kidney Disease stage3 and 4Type 2 Diabetes Mellitus
Maria Eugenia Galván Plata 196
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Testing effectiveness (Phase 2)Study completedNCT01712061
What this trial is testing

Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathy
Pfizer 226
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Large-scale testing (Phase 3)Study completedNCT00004266
What this trial is testing

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 160
Large-scale testing (Phase 3)Ended earlyNCT02410005
What this trial is testing

Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)

Who this might be right for
Diabetic Nephropathies
Weill Cornell Medical College in Qatar 56
Not applicableUnknownNCT05681286
What this trial is testing

CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy

Who this might be right for
Type 2 DM /Diabetic Nephropathy
Assiut University 70
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Not applicableStudy completedNCT06833541
What this trial is testing

Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine 556
Testing effectiveness (Phase 2)Study completedNCT01109212
What this trial is testing

The Effects of Bindarit in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Aziende Chimiche Riunite Angelini Francesco S.p.A 100
Post-approval studies (Phase 4)Study completedNCT00234871
What this trial is testing

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Who this might be right for
HypertensionDiabetesProteinuria
Abbott 357
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Not applicableStudy completedNCT02001532
What this trial is testing

Arterial Stiffness and Complication Risk in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes ComplicationsDiabetic Angiopathies+1 more
Aarhus University Hospital 140
Post-approval studies (Phase 4)Study completedNCT03047278
What this trial is testing

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Who this might be right for
Neuropathic PainType 2 Diabetes MellitusDiabetic Neuropathy, Painful
Natalia Valadares de Moraes 29
Post-approval studies (Phase 4)Study completedNCT00363987
What this trial is testing

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Who this might be right for
Diabetic Nephropathy
Fresenius Kabi 179
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Post-approval studies (Phase 4)Study completedNCT00419835
What this trial is testing

Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

Who this might be right for
Macroalbuminuric Diabetic Nephropathy
University of Sao Paulo 80
Post-approval studies (Phase 4)Active Not RecruitingNCT00725127
What this trial is testing

Chronotherapy with Low-dose Aspirin for Primary Prevention

Who this might be right for
Type 2 Diabetes
University of Vigo 3,200
Next Page